Institutional investors purchased a net $518.8 thousand shares of ALBO during the quarter ended September 2017. This may signal that the smart money is gaining interest in this company as the 27.01% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Other industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
INVUS PUBLIC EQUITIES ADVISORS L... Bought 300.0 Thousand shares of Albireo Pharma Inc